The detection of Chlamydia pneumoniae in atherosclerotic plaques of Australian subjects

被引:6
作者
Cochrane, M [1 ]
Kalle, WHJ [1 ]
Roffey, P [1 ]
Moriarty, HT [1 ]
机构
[1] Charles Sturt Univ, Sch Biomed Sci, Fac Hlth Studies, Wagga Wagga, NSW 2678, Australia
关键词
atherosclerosis; cardiovascular diseases; Chlamydia pneumoniae;
D O I
10.1080/00313020220131363
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aim: To determine whether the common respiratory pathogen, Chlamydia pneumoniae, was associated with atherosclerotic plaques in Australian subjects. Methods: A total of 29 coronary atherosclerotic lesions and 18 normal coronary arterial samples were tested for the presence of C. pneumoniae by PCR and immunofluorescence methods. Results: Chlamydia pneumoniae was detected in 15 of the atheromatous lesions as well as in three of the normal tissues; the immunofluorescence assay was more sensitive (P=0.028) than PCR (P=0.26). Conclusions: These findings contradict previous Australian studies which did not detect C. pneumoniae in atherosclerotic plaques, thereby discounting the speculation that its absence was likely due to geographical variation. The detection of the bacterium in some of the normal tissues suggests that C. pneumoniae infection might be an initial trigger of atherosclerotic development.
引用
收藏
页码:270 / 274
页数:5
相关论文
共 21 条
[1]  
ASCHE V, 1994, TODAYS LIFE SCI, V6, P66
[2]   DETECTION OF CHLAMYDIA-PNEUMONIAE BY POLYMERASE CHAIN-REACTION [J].
CAMPBELL, LA ;
MELGOSA, MP ;
HAMILTON, DJ ;
KUO, CC ;
GRAYSTON, JT .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (02) :434-439
[3]  
Chiu B, 1997, CIRCULATION, V96, P2144
[4]   Lack of association between seropositivity to Chlamydia pneumoniae and carotid atherosclerosis [J].
Coles, KA ;
Plant, AJ ;
Riley, TV ;
Smith, DW ;
McQuillan, BM ;
Thompson, PL .
AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (07) :825-828
[5]   Rabbit model for Chlamydia pneumoniae infection [J].
Fong, IW ;
Chiu, B ;
Viira, E ;
Fong, MW ;
Jang, D ;
Mahony, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (01) :48-52
[6]   Antibiotic treatment of Chlamydia pneumoniae for secondary prevention of cardiovascular events [J].
Grayston, JT .
CIRCULATION, 1998, 97 (17) :1669-1670
[7]   CHLAMYDIA-PNEUMONIAE (TWAR) IN ATHEROSCLEROSIS OF THE CAROTID-ARTERY [J].
GRAYSTON, JT ;
KUO, CC ;
COULSON, AS ;
CAMPBELL, LA ;
LAWRENCE, RD ;
LEE, MJ ;
STRANDNESS, ED ;
WANG, SP .
CIRCULATION, 1995, 92 (12) :3397-3400
[8]  
Gupta S, 1997, CIRCULATION, V96, P404
[9]   Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study [J].
Gurfinkel, E ;
Bozovich, G ;
Daroca, A ;
Beck, E ;
Mautner, B .
LANCET, 1997, 350 (9075) :404-407
[10]   The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae [J].
Hu, H ;
Pierce, GN ;
Zhong, GM .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (05) :747-753